$ACST Plain low glycemic starch killed an otherwise stellar performance of Capre. Vascepa did not lower trigs by 30% in any trial. I told all of you that it would make the margins tight. This is unheard of and calls into question the results of all Amarin $AMRN trials including REDUCE-IT. Lawsuits will follow in 3, 2, 1...
  • 2
  • 18